Cite
MLA Citation
P. Zinzani et al.. “Efficacy and safety of pembrolizumab in relapsed/refractory primary mediastinal large B‐cell lymphoma (rrPMBCL): interim analysis of the KEYNOTE‐170 phase 2 trial.” Hematological oncology, vol. 35, n.d., pp. 62–63. http://access.bl.uk/ark:/81055/vdc_100047521632.0x000031